Journal of Medicinal Chemistry · 2015 · 137 citations · 7 references
PharmacyMedicinal ChemistryPharmacologyBiochemical PharmacologyDrug DesignDrug DiscoveryEnzyme InhibitionIron MetabolismNanomedicineOxidative Damage To BiomoleculesAdme ProfilingGlutathione Peroxidase 4Glutathione Peroxidase ActivityHydrolysisInherent StabilityInhibitor PerformanceInhibitor ScreeningOrgan Ischemia-reperfusion Injury
Ferroptosis is a nonapoptotic, iron-catalyzed form of regulated necrosis that is critically dependent on glutathione peroxidase 4 (GPX4). It has been shown to contribute to liver and kidney ischemia reperfusion injury in mice. A chemical inhibitor discovered by high-throughput screening displayed inhibition of ferroptosis with nanomolar activity and was dubbed ferrostatin-1 (fer-1). Ferrostatins inhibit oxidative lipid damage, but suffer from inherent stability problems due to the presence of an ester moiety. This limits the application of these molecules in vivo, due to rapid hydrolysis of the ester into the inactive carboxylic acid. Previous studies highlighted the importance of the ethyl ester and suggested steric modifications of the ester for generating improved molecules. In this study, we report the synthesis of novel ferroptosis inhibitors containing amide and sulfonamide moieties with improved stability, single digit nanomolar antiferroptotic activity, and good ADME properties suitable for application in in vivo disease models.
7
Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
Scott J. Dixon, Kathryn M. Lemberg, Michael R. Lamprecht et al. · Cell · 2012 · 18.1K citations · Full text
Regulation of Ferroptotic Cancer Cell Death by GPX4
Wan Seok Yang, Rohitha Sriramaratnam, Matthew Welsch et al. · Cell · 2014 · 7.5K citations · Full text
Synchronized renal tubular cell death involves ferroptosis
Andreas Linkermann, Rachid Skouta, Nina Himmerkus et al. · Proceedings of the National Academy of Sciences · 2014 · 1.1K citations · Full text
Medicine, Cell Biology, Nephrology +16